Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome (2023)
Attributed to:
Personalised management of atypical haemolytic uraemic syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/tp.0000000000004355
PubMed Identifier: 36413152
Publication URI: http://europepmc.org/abstract/MED/36413152
Type: Journal Article/Review
Parent Publication: Transplantation
Issue: 4
ISSN: 0041-1337